Nilutamide: an antiandrogen for the treatment of prostate cancer.
about
Hormonal therapy in metastatic prostate cancer: current perspectives and controversiesNovel, potent anti-androgens of therapeutic potential: recent advances and promising developments.CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: potential role in prostate cancer bone tropismTolerability of Antiandrogens in the Treatment of Prostate Cancer
P2860
Nilutamide: an antiandrogen for the treatment of prostate cancer.
description
1997 nî lūn-bûn
@nan
1997 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Nilutamide: an antiandrogen for the treatment of prostate cancer.
@ast
Nilutamide: an antiandrogen for the treatment of prostate cancer.
@en
Nilutamide: an antiandrogen for the treatment of prostate cancer.
@nl
type
label
Nilutamide: an antiandrogen for the treatment of prostate cancer.
@ast
Nilutamide: an antiandrogen for the treatment of prostate cancer.
@en
Nilutamide: an antiandrogen for the treatment of prostate cancer.
@nl
prefLabel
Nilutamide: an antiandrogen for the treatment of prostate cancer.
@ast
Nilutamide: an antiandrogen for the treatment of prostate cancer.
@en
Nilutamide: an antiandrogen for the treatment of prostate cancer.
@nl
P2860
P1476
Nilutamide: an antiandrogen for the treatment of prostate cancer.
@en
P2093
M T Holdsworth
P2860
P356
10.1177/106002809703100112
P407
P577
1997-01-01T00:00:00Z